Anvisa authorizes clinical trial of tetravalent influenza vaccine
The National Health Surveillance Agency (Anvisa) authorized the start of the phase III clinical trial of the tetravalent influenza vaccine, ...
Folha Nobre - Desde 2013 - ©
The National Health Surveillance Agency (Anvisa) authorized the start of the phase III clinical trial of the tetravalent influenza vaccine, ...